LitCovid-sample-Enju  

PMC:7199903 / 274-643 JSONTXT 15 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T39 0-5 NN denotes spike
T40 6-9 VBZ denotes has
T41 10-12 CD denotes 22
T42 13-26 NN denotes glycosylation
T43 27-32 NNS denotes sites
T44 34-37 WRB denotes How
T45 38-43 DT denotes these
T46 44-49 NNS denotes sites
T47 50-53 VBP denotes are
T48 54-66 VBN denotes glycosylated
T49 67-70 MD denotes may
T50 71-77 VB denotes affect
T51 78-83 WDT denotes which
T52 84-89 NNS denotes cells
T53 90-93 DT denotes the
T54 94-99 NN denotes virus
T55 100-103 MD denotes can
T56 104-110 VB denotes infect
T57 111-114 CC denotes and
T58 115-120 MD denotes could
T59 121-127 VB denotes shield
T60 128-132 DT denotes some
T61 133-141 NNS denotes epitopes
T62 142-146 IN denotes from
T63 147-155 NN denotes antibody
T64 156-170 NN denotes neutralization
T65 172-180 NNP denotes Watanabe
T66 181-183 FW denotes et
T67 184-187 FW denotes al.
T68 188-197 VBN denotes expressed
T69 198-201 CC denotes and
T70 202-210 VBN denotes purified
T71 211-222 JJ denotes recombinant
T72 223-235 VBN denotes glycosylated
T73 236-241 NN denotes spike
T74 242-249 NNS denotes trimers
T75 249-250 -COMMA- denotes ,
T76 251-262 VBD denotes proteolysed
T77 263-267 PRP denotes them
T78 268-270 TO denotes to
T79 271-276 VB denotes yield
T80 277-290 NNS denotes glycopeptides
T81 291-301 VBG denotes containing
T82 302-303 DT denotes a
T83 304-310 JJ denotes single
T84 311-317 NN denotes glycan
T85 317-318 -COMMA- denotes ,
T86 319-322 CC denotes and
T87 323-333 VBD denotes determined
T88 334-337 DT denotes the
T89 338-349 NN denotes composition
T90 350-352 IN denotes of
T91 353-356 DT denotes the
T92 357-363 NN denotes glycan
T93 364-369 NNS denotes sites
R38 T43 T40 arg2Of sites,has
R39 T43 T41 arg1Of sites,22
R40 T43 T42 arg1Of sites,glycosylation
R41 T48 T44 arg1Of glycosylated,How
R42 T46 T45 arg1Of sites,these
R43 T46 T47 arg1Of sites,are
R44 T48 T47 arg2Of glycosylated,are
R45 T46 T48 arg2Of sites,glycosylated
R46 T44 T49 arg1Of How,may
R47 T50 T49 arg2Of affect,may
R48 T44 T50 arg1Of How,affect
R49 T51 T50 arg2Of which,affect
R50 T52 T51 arg1Of cells,which
R51 T54 T53 arg1Of virus,the
R52 T54 T55 arg1Of virus,can
R53 T56 T55 arg2Of infect,can
R54 T54 T56 arg1Of virus,infect
R55 T52 T56 arg2Of cells,infect
R56 T50 T57 arg1Of affect,and
R57 T59 T57 arg2Of shield,and
R58 T44 T58 arg1Of How,could
R59 T59 T58 arg2Of shield,could
R60 T44 T59 arg1Of How,shield
R61 T61 T59 arg2Of epitopes,shield
R62 T61 T60 arg1Of epitopes,some
R63 T61 T62 arg1Of epitopes,from
R64 T64 T62 arg2Of neutralization,from
R65 T64 T63 arg1Of neutralization,antibody
R66 T74 T65 arg1Of trimers,Watanabe
R67 T67 T66 arg1Of al.,et
R68 T65 T67 arg1Of Watanabe,al.
R69 T67 T68 arg2Of al.,expressed
R70 T68 T69 arg1Of expressed,and
R71 T70 T69 arg2Of purified,and
R72 T67 T70 arg2Of al.,purified
R73 T74 T71 arg1Of trimers,recombinant
R74 T74 T72 arg2Of trimers,glycosylated
R75 T74 T73 arg1Of trimers,spike
R76 T86 T75 arg1Of and,","
R77 T74 T76 arg1Of trimers,proteolysed
R78 T77 T76 arg2Of them,proteolysed
R79 T79 T76 arg3Of yield,proteolysed
R80 T79 T78 arg1Of yield,to
R81 T77 T79 arg1Of them,yield
R82 T80 T79 arg2Of glycopeptides,yield
R83 T80 T81 arg1Of glycopeptides,containing
R84 T84 T81 arg2Of glycan,containing
R85 T84 T82 arg1Of glycan,a
R86 T84 T83 arg1Of glycan,single
R87 T86 T85 arg1Of and,","
R88 T76 T86 arg1Of proteolysed,and
R89 T87 T86 arg2Of determined,and
R90 T74 T87 arg1Of trimers,determined
R91 T89 T87 arg2Of composition,determined
R92 T89 T88 arg1Of composition,the
R93 T89 T90 arg1Of composition,of
R94 T93 T90 arg2Of sites,of
R95 T93 T91 arg1Of sites,the
R96 T93 T92 arg1Of sites,glycan